Entecavir (ETV) results in continued virologic and biochemical improvement through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)

Yurdaydin C., Sollano J., Hadziyannis S., Kaymakoglu S., Sherman M., Brett-Smith H., ...More

LIVER INTERNATIONAL, vol.26, pp.14, 2006 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 26
  • Publication Date: 2006
  • Title of Journal : LIVER INTERNATIONAL
  • Page Numbers: pp.14